FDA Commissioner Marty Makary Resigns
Marty Makary, the U.S. Food and Drug Administration Commissioner, is stepping down from his position. Deputy Commissioner Kyle Diamantas will temporarily take over the leadership of the FDA. The announcement of Makary's resignation was reported by Politico, based on information from an administration official.
In a significant leadership shift, U.S. Food and Drug Administration Commissioner Marty Makary has announced his resignation, according to a report by Politico.
The report, citing an administration official, revealed that Makary will officially step down on Tuesday. His departure marks the end of his tenure at the FDA.
Following Makary's resignation, Deputy Commissioner Kyle Diamantas is set to assume leadership of the organization in an acting capacity. This change comes at a pivotal time for the FDA, as it continues to navigate various regulatory challenges and advancements in medical science.
ALSO READ
-
FDA in Turmoil: Makary's Resignation Sparks Controversy
-
Controversy and Change: FDA Chief's Resignation Unfolds Amid Pressure
-
UPDATE 3-FDA commissioner Makary is resigning, sources say
-
FDA Leadership Shift: Commissioner Makary Resigns Amid Pressure
-
UPDATE 6-Trump plans to fire US FDA chief Makary, sources say
Google News